Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value: $553M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 15,238,782 | $205M | 37.0% | $24.19 | — | COM | 676079106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $67.79M | 12.3% | $16.31 | +51.1% | COM | 77313F106 |
| HRTX | HERON THERAPEUTICS INC | 2,896,904 | $42.93M | 7.8% | $14.10 | +10.7% | COM | 427746102 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 599,091 | $38.95M | 7.0% | $73.11 | — | COM | G11196105 |
| ANAB | ANAPTYSBIO INC | 2,628,678 | $38.77M | 7.0% | $21.51 | -16.1% | COM | 032724106 |
| — | LA JOLLA PHARMACEUTICAL CO | 9,405,490 | $37.9M | 6.9% | $10.35 | — | COM | 503459604 |
| BIO | BIO RAD LABS INC | 40,000 | $20.62M | 3.7% | $367.68 | +37.8% | CL A | 090572207 |
| RLMD | RELMADA THERAPEUTICS INC | 500,000 | $18.81M | 3.4% | $28.22 | +37.0% | COM | 75955J402 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 160,000 | $16.16M | 2.9% | $95.05 | +15.4% | COM | 91307C102 |
| SGMO | SANGAMO THERAPEUTICS INC | 1,578,795 | $14.92M | 2.7% | $7.42 | +45.8% | COM | 800677106 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,246,121 | $12.57M | 2.3% | $15.21 | -33.1% | COM | 74587V107 |
| CHRS | COHERUS BIOSCIENCES INC | 550,000 | $10.09M | 1.8% | $17.91 | +3.9% | COM | 19249H103 |
| — | AVROBIO INC | 700,000 | $9.114M | 1.6% | $15.15 | — | COM | 05455M100 |
| — | LIFESCI ACQUISITION CORP | 500,000 | $6.8M | 1.2% | $10.00 | — | UNIT 03/31/2025 | 53228P208 |
| — | BCTG ACQUISITION CORP | 468,750 | $4.856M | 0.9% | $10.36 | — | COM | 05492W103 |
| EGRX | EAGLE PHARMACEUTICALS INC | 62,262 | $2.645M | 0.5% | $50.18 | -12.8% | COM | 269796108 |
| VNDA | VANDA PHARMACEUTICALS INC | 191,426 | $1.849M | 0.3% | $12.40 | -13.8% | COM | 921659108 |
| PRTA | PROTHENA CORP PLC | 178,688 | $1.785M | 0.3% | $11.57 | +4.0% | SHS | G72800108 |
| CTMX | CYTOMX THERAPEUTICS INC | 112,880 | $751K | 0.1% | $6.97 | +6.4% | COM | 23284F105 |
| — | TENAX THERAPEUTICS INC | 460,000 | $708K | 0.1% | $0.90 | — | COM NEW | 88032L209 |